Krebs Biochemicals & Industr Q4 Results Live : loss falls by 15.75% YOY
Krebs Biochemicals & Industr Q4 Results Live : Revenue increased by 4.47% YoY & loss decreased by 15.75% YoY
Krebs Biochemicals & Industr Q4 Results Live : Krebs Biochemicals & Industr announced their Q4 results on 21 May, 2024, with a 4.47% increase in revenue and a 15.75% decrease in loss compared to the same quarter last year.
However, the company saw a decline of 7.74% in revenue and an increase of 17.47% in loss compared to the previous quarter.
The Selling, general & administrative expenses showed a significant decline of 12.78% sequentially and 14.02% year-on-year.
Operating income was down by 25.26% quarter-on-quarter but saw an increase of 21.61% year-on-year for Krebs Biochemicals & Industr.
The Earnings Per Share (EPS) for Q4 was reported at ₹-2.72, showing an 11.05% increase year-on-year.
In terms of returns, the company delivered 0.15% in the last 1 week, while showing negative returns of -16.98% in the last 6 months and -15.12% year-to-date.
Krebs Biochemicals & Industr currently holds a market cap of ₹143.38 Cr with a 52-week high/low of ₹93.95 & ₹59.2 respectively.
Krebs Biochemicals & Industr Financials
| Period | Q4 | Q3 | Q-o-Q Growth | Q4 | Y-o-Y Growth |
|---|---|---|---|---|---|
| Total Revenue | 11.97 | 12.98 | -7.74% | 11.46 | +4.47% |
| Selling/ General/ Admin Expenses Total | 3.88 | 4.44 | -12.78% | 4.51 | -14.02% |
| Depreciation/ Amortization | 1.67 | 1.73 | -3.39% | 1.48 | +12.95% |
| Total Operating Expense | 16.76 | 16.8 | -0.23% | 17.56 | -4.59% |
| Operating Income | -4.79 | -3.82 | -25.26% | -6.1 | +21.61% |
| Net Income Before Taxes | -5.85 | -4.98 | -17.47% | -6.94 | +15.75% |
| Net Income | -5.85 | -4.98 | -17.47% | -6.94 | +15.75% |
| Diluted Normalized EPS | -2.72 | -2.31 | -17.75% | -3.06 | +11.05% |
Catch all the Business News , Corporate news , Breaking News Events and Latest News Updates on Live Mint. Download The Mint News App to get Daily Market Updates.